Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Summary
Blankestijn PJ  
Effects of Eprosartan in Chronic Kidney Disease

Journal of Clinical and Basic Cardiology 2005; 8 (1-4): 15-17
Journal of Clinical and Basic Cardiology 2006; 9 (Sonderheft 1): 13-15

PDF    Summary    Figures   

Fig. 1: Eprosartan



Keywords: Angiotensin-II-AntagonistAngiotensin-II-RezeptorblockadeEprosartanHypertonieKardiologieNierenerkrankungSympathikusangiotensin II antagonistangiotensin receptor blockadecardiologychronic kidney diseaseEprosartanhypertensionsympathetic nervous system

Increased activities of the renin system and the sympathetic nervous system are key contributors to the pathogenesis of hypertension in chronic kidney disease patients. Eprosartan is an angiotensin II receptor antagonist, which effectively reduces muscle sympathetic nerve activity (MSNA) in chronic kidney disease patients.
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung